KR960010020A - 조혈 기능 항진제 - Google Patents

조혈 기능 항진제 Download PDF

Info

Publication number
KR960010020A
KR960010020A KR1019950029361A KR19950029361A KR960010020A KR 960010020 A KR960010020 A KR 960010020A KR 1019950029361 A KR1019950029361 A KR 1019950029361A KR 19950029361 A KR19950029361 A KR 19950029361A KR 960010020 A KR960010020 A KR 960010020A
Authority
KR
South Korea
Prior art keywords
methylhistitin
valenin
anserine
methylhistidine
group
Prior art date
Application number
KR1019950029361A
Other languages
English (en)
Inventor
마사미 하라다
찌-보 양
Original Assignee
도리이 신이치로
산토리 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6215813A external-priority patent/JPH0881371A/ja
Priority claimed from JP6216236A external-priority patent/JPH0881372A/ja
Application filed by 도리이 신이치로, 산토리 가부시키가이샤 filed Critical 도리이 신이치로
Publication of KR960010020A publication Critical patent/KR960010020A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은, 안세린, 발레닌, π-메틸히스티딘 및 τ-메틸히스티틴으로 이루어진 그룹에서 선택된 하나 이상의 이미다졸 화합물을 포함하는 조혈 기능 항진제에 관한 것이다.

Description

조형 기능 항진제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 안세린, 발레닌, π-메틸히스티딘 및 τ-메틸히스티틴으로 이루어진 그룹에서 선택된 하나 이상의 이미다졸 화합물을 포함하는 조혈 기능 항진제
  2. 안세린, 발레닌, π-메틸히스티딘 및 τ-메틸히스티틴의 그룹에서 선택된 하나 이상의 이미다졸 화합물 또는 이를 주성분으로 하는 추출물을 포함하는, 조혈 기능 항진작용을 하는 음식물
  3. 제2항에 있어서, 안세린, 발레닌, π-메틸히스티딘 및 τ-메틸히스티틴의 그룹에서 선택된 하나 이상의 이미다졸 화합물을 1일 50㎎ 내지 5g으로 섭취할 수 있도록 한 형태임을 특징으로 하는, 조혈 기능 항진작용을 하는 음식물
  4. 안세린, 발레닌, π-메틸히스티딘 및 τ-메틸히스티틴을 실질적으로 함유하지 않는 음식물에 안세린, 발레닌, π-메틸히스티딘 및 τ-메틸히스티틴의 그룹에서 선택된 하나 이상의 이미다졸 화합물 또는 이를 주성분으로 추출물을 첨가함을 특징으로 하여, 조혈 기능 항진작용을 하는 음식물을 제조하는 방법
  5. 안세린, 카르노신, 발레닌, 호모카르노신, π-메틸히스티딘 및 τ-메틸히스티틴의 그룹에서 선택된 하나 이상의 이미다졸 화합물을 유효성분으로 하는, 적혈구 수의 감소에 기인하는 의학적 증상의 예방 또는 개선제
  6. 안세린, 카르노신, 발레닌, 호모카르노신, π-메틸히스티딘 및 τ-메틸히스티틴의 그룹에서 선택된 하나 이상의 이미다졸 화합물 또는 이를 주성분으로 하는 추출물을 함유하는, 적혈구 수의 감소에 기인하는 의학적 증상의 예방 또는 개선작용을 하는 음식물
  7. 제6항에 있어서, 적혈구 수의 감소에 기인하는 의학적 증상이 조혈 기능 억제성 또는 출혈성의 빈혈임을 특징으로 하는 음식물
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950029361A 1994-09-09 1995-09-07 조혈 기능 항진제 KR960010020A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP94-216236 1994-09-09
JP94-215813 1994-09-09
JP6215813A JPH0881371A (ja) 1994-09-09 1994-09-09 造血機能亢進剤
JP6216236A JPH0881372A (ja) 1994-09-09 1994-09-09 赤血球数の減少に起因する医学的症状の予防及び改善剤

Publications (1)

Publication Number Publication Date
KR960010020A true KR960010020A (ko) 1996-04-20

Family

ID=26521066

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950029361A KR960010020A (ko) 1994-09-09 1995-09-07 조혈 기능 항진제

Country Status (4)

Country Link
EP (1) EP0710485A1 (ko)
KR (1) KR960010020A (ko)
AU (1) AU692903B2 (ko)
CA (1) CA2157835A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US6855727B2 (en) 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
EP2052735B1 (en) 2007-10-22 2016-05-11 Lytone Enterprise, Inc. Pharmaceutical composition and kit comprising anserine for rapidly reducing uric acid in blood
CN104304549B (zh) * 2014-01-17 2016-08-24 韩波 抗辐射导致红细胞减少综合征的茶膏及其制备方法
JP2015193582A (ja) * 2014-03-28 2015-11-05 国立大学法人 東京大学 イミダゾールジペプチドを含む剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5843756A (ja) 1981-09-11 1983-03-14 Ajinomoto Co Inc 改善された呈味を有する食品又は調味料の製造法
JPS61186322A (ja) 1985-02-13 1986-08-20 Nippon Univ 免疾調節剤
US4619326A (en) 1985-04-19 1986-10-28 Shell California Production Inc. Liner hanger with brass packer
JPH0693827B2 (ja) 1986-11-22 1994-11-24 味の素株式会社 カツオ煮汁よりのジペプチド分取精製方法
JPS6442430A (en) 1987-08-11 1989-02-14 Nippon Univ Side effect remover for chemotherapeutic agent
JPH0193526A (ja) 1987-10-05 1989-04-12 Kaneshiro Nagai 白血球減少の回復剤
JPH0235057A (ja) 1988-04-26 1990-02-05 Kinuko Nagai 機能性食品
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
JP2939301B2 (ja) 1990-05-07 1999-08-25 日本新薬株式会社 経口摂取組成物
JP3116372B2 (ja) 1990-11-21 2000-12-11 日本新薬株式会社 酸化防止法
JPH04187610A (ja) 1990-11-21 1992-07-06 Nippon Shinyaku Co Ltd 化粧料
JPH0797323A (ja) * 1993-05-07 1995-04-11 Suntory Ltd 鉄吸収促進剤

Also Published As

Publication number Publication date
EP0710485A1 (en) 1996-05-08
AU3052195A (en) 1996-03-21
CA2157835A1 (en) 1996-03-10
AU692903B2 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
GB8507058D0 (en) Pharmaceutical & dietary compositions
EP1743630A3 (en) Pharmaceutical combination
WO1999066031A3 (de) Pharmazeutisches faktor vii-präparat
WO2002039978A8 (de) Enteral zu verabreichendes supplement zur parenteralen ernährung oder partiellen enteralen/oralen ernährung bei kritisch kranken, chronisch kranken und mangelernährten
BRPI9902623B1 (pt) composições em pó e em emulsão com vitaminas, comprimido efervescente, bebida e método de produção da composição em pó.
CA2030838A1 (en) Preparations containing l-carnitine
CA2397447A1 (en) Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications
FR2754820B1 (fr) Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant
CA2326485A1 (en) Anticancer compositions
CA2343732A1 (en) Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
WO2005007137A8 (de) Ambroxolhaltige tabletten
PT1063901E (pt) Alimentos contendo biotina e outras vitaminas b
KR960010020A (ko) 조혈 기능 항진제
CA2447525A1 (en) Pharmaceutical and cosmetic compositions against skin aging
CA2305598A1 (en) Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects
CA2172603A1 (en) Solid Substances Comprising Valproic Acid and Sodium Valproate
AU7028598A (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
CA2518738A1 (en) Method and composition for preventing or reducing diarrhea
CA2383755A1 (en) Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
RU95105341A (ru) Водка "презент"
KR960010001A (ko) 트레오닌을 함유한 알콜대사 촉진용 조성물
RU94008858A (ru) Фармацевтическая композиция, содержащая l-аспартат или l-аспарагин, применяемая для предотвращения спиртовых отравлений, и способ предупреждения алкогольных отравлений
AU1660399A (en) Pharmaceutical preparations

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application